Skip to main content
Back
GILD logo

Gilead Sciences, Inc.

Data quality: 100%
GILD
NASDAQ Healthcare Drug Manufacturers - General
$137.34
▲ $0.13 (0.09%)
Mkt Cap: 170.50B
Day Range
$136.44 $139.80
52-Week Range
$93.37 $157.29
Volume
7,360,842
50D / 200D Avg
$141.92 / $123.02
Prev Close
$137.21

Price History

Financial Trends

Peer Comparison

vs Healthcare sector median (626 peers)

Metric Stock Sector Median
P/E 20.0 0.4
P/B 7.5 2.9
ROE % 40.6 3.7
Net Margin % 28.9 3.8
Rev Growth 5Y % 1.9 10.0
D/E 1.1 0.2

Insider Trading Activity

Buy ratio (90d) 0.0%
20 transactions
Date Insider Type Shares Price Value
Mar 16, 2026
Mercier Johanna
Chief Comm & Corp Aff Officer
sell 3,000 $144.23 $432,690
Mar 16, 2026
Dickinson Andrew D
Chief Financial Officer
sell 3,000 $144.23 $432,690
Feb 27, 2026
Berger Dietmar
Chief Medical Officer
grant 8,530
Feb 27, 2026
Cain Wettan Keeley M
EVP Gen Counsel, Legal & Comp
grant 470
Jan 20, 2026
Bluestone Jeffrey
Director
other 10,000 $67.45
Jan 20, 2026
Bluestone Jeffrey
Director
sell 5,000 $123.50 $617,500
Dec 29, 2025
O'Day Daniel Patrick
Chairman & CEO
sell 10,000 $124.83 $1,248,272
Dec 15, 2025
Dickinson Andrew D
Chief Financial Officer
sell 3,000 $122.00 $366,000
Nov 28, 2025
Bluestone Jeffrey
Director
other 10,000 $64.92
Nov 28, 2025
Bluestone Jeffrey
Director
sell 5,000 $125.08 $625,400
Nov 17, 2025
Dickinson Andrew D
Chief Financial Officer
sell 2,500 $125.23 $313,075
Oct 15, 2025
Dickinson Andrew D
Chief Financial Officer
sell 2,500 $118.08 $295,200
Sep 15, 2025
Mercier Johanna
Chief Commercial Officer
sell 3,000 $113.57 $340,710
Sep 10, 2025
Mercier Johanna
Chief Commercial Officer
other 9,507
Jul 15, 2025
Mercier Johanna
Chief Commercial Officer
sell 3,000 $111.03 $333,090
Jun 16, 2025
Dickinson Andrew D
Chief Financial Officer
sell 2,500 $110.17 $275,425
Jun 10, 2025
Telman Deborah H
EVP, Corporate Affairs & GC
other 3,056
Jun 10, 2025
Wilfong Diane E.
Interim Corp Controller & CAO
other 2,180
Jun 10, 2025
Dickinson Andrew D
Chief Financial Officer
other 9,146
May 15, 2025
Dickinson Andrew D
Chief Financial Officer
sell 2,500 $99.82 $249,550

Key Takeaways

Revenue grew 1.90% annually over 5 years — modest growth
Earnings grew 1672.92% over the past year
ROE of 40.57% indicates high profitability
Net margin of 28.90% shows strong profitability
Generating 9.46B in free cash flow
PEG of 0.01 suggests growth is underpriced

Growth

Revenue Growth (5Y)
1.90%
Revenue (1Y)2.40%
Earnings (1Y)1672.92%
FCF Growth (3Y)12.88%

Quality

Return on Equity
40.57%
ROIC18.77%
Net Margin28.90%
Op. Margin40.14%

Safety

Debt / Equity
1.09
Current Ratio1.68
Interest Coverage11.54

Valuation

P/E Ratio
20.03
P/B Ratio7.54
EV/EBITDA15.87
Dividend Yield0.03%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 2.40% Revenue Growth (3Y) 4.20%
Earnings Growth (1Y) 1672.92% Earnings Growth (3Y) 22.56%
Revenue Growth (5Y) 1.90% Earnings Growth (5Y) 8.13%
Profitability
Revenue (TTM) 29.44B Net Income (TTM) 8.51B
ROE 40.57% ROA 14.42%
Gross Margin 86.69% Operating Margin 40.14%
Net Margin 28.90% Free Cash Flow (TTM) 9.46B
ROIC 18.77% FCF Growth (3Y) 12.88%
Safety
Debt / Equity 1.09 Current Ratio 1.68
Interest Coverage 11.54 Dividend Yield 0.03%
Valuation
P/E Ratio 20.03 P/B Ratio 7.54
P/S Ratio 5.79 PEG Ratio 0.01
EV/EBITDA 15.87 Dividend Yield 0.03%
Market Cap 170.50B Enterprise Value 187.52B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 29.44B 28.75B 27.12B 27.28B 27.31B
Net Income 8.51B 480.00M 5.67B 4.59B 6.23B
EPS (Diluted) 6.78 0.38 4.50 3.64 4.93
Gross Profit 25.52B 22.50B 20.62B 21.62B 20.70B
Operating Income 11.82B 1.66B 7.61B 7.33B 9.92B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 59.02B 59.00B 62.13B 63.17B 67.95B
Total Liabilities 36.41B 39.75B 39.38B 41.96B 46.89B
Shareholders' Equity 22.62B 19.33B 22.83B 21.24B 21.07B
Total Debt 24.59B 26.71B 24.99B 25.23B 26.70B
Cash & Equivalents 7.56B 9.99B 6.09B 5.41B 5.34B
Current Assets 19.89B 19.17B 16.09B 14.44B 14.77B
Current Liabilities 11.81B 12.00B 11.28B 11.24B 11.61B